Following encouraging trial findings , retatrutide, a new peptide treatment for managing type 2 hyperglycemia , has secured conditional approval from Great Britain's Drug and Regulatory Agency ( MHRA https://deweynvtq462845.popup-blog.com/39961000/retatrutide-treatment-peptide-british-approval-and-availability